Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, April 9, 2012

Cardio Notes: Coumadin Home Testing Viable

I hated having to get my INR levels tested when I was on warfarin(rat poison). I wonder how long before its available.
http://www.medpagetoday.com/Cardiology/Arrhythmias/32085?utm_source=cardiodaily&utm_medium=email&utm_content=aha&utm_campaign=04-09-12&eun=gd3r&userid=424561&email=oc1dean@yahoo.com&mu_id=5523591

Warfarin Self-Testing Scores Big

Patients on warfarin (Coumadin) who used a self-testing device were able to maintain a high rate of time in target range, a retrospective analysis of the STABLE study found.

Of the nearly 30,000 patients analyzed, the rate of time in target range for those who self-tested weekly was 73%, while the overall rate, which included variable testing, was 69%, according to Jack Ansell, MD, from Lenox Hill Hospital in New York City.

Compared with younger patients (46 to 64 years), older patients (65 to 74 years) had higher a rate of time in target range (67% versus 72%), Ansell reported at the recent American College of Cardiology meeting.

Comparative times in target range from recent large trials evaluating the new oral anticoagulants have included:

Ansell said that home monitoring achieves better outcomes because it's convenient for patients, the test is consistent, and the immediate awareness of test results empowers patients and enhances compliance.

Three-quarters of the patients in the STABLE study were on warfarin for nonvalvular atrial fibrillation, and these patients had better rates in therapeutic range compared with patients with other indications such as valvular disease alone or with atrial fibrillation and venous thromboembolism. Men had a slight edge over women in percent time in target range (72% versus 66%).
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)